Quarterly report · Q2
2590.TEDINET S100P4E7
Period2022-01-21 → 2022-07-20
Filed2022-09-02
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥79.8bn | 2022-01-21 → 2022-07-20 | Cons. | Net sales |
| Revenue | ¥162.6bn | 2021-01-21 → 2022-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥79.9bn | 2021-01-21 → 2021-07-20 | Cons. | Net sales |
| Operating income | ¥723m | 2022-01-21 → 2022-07-20 | Cons. | Operating income |
| Operating income | ¥2.7bn | 2021-01-21 → 2021-07-20 | Cons. | Operating income |
| Ordinary income | ¥461m | 2022-01-21 → 2022-07-20 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2021-01-21 → 2022-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2021-01-21 → 2021-07-20 | Cons. | Ordinary income |
| Profit before tax | ¥351m | 2022-01-21 → 2022-07-20 | Cons. | Income before income taxes |
| Profit before tax | ¥2.8bn | 2021-01-21 → 2021-07-20 | Cons. | Income before income taxes |
| Net income (owners) | −¥869m | 2022-01-21 → 2022-07-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.0bn | 2021-01-21 → 2022-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2021-01-21 → 2021-07-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥909m | 2022-01-21 → 2022-07-20 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2021-01-21 → 2021-07-20 | Cons. | Profit loss |
| Total assets | ¥170.3bn | at 2022-07-20 | Cons. | Assets |
| Total assets | ¥159.0bn | at 2022-01-20 | Cons. | Assets |
| Total assets | ¥171.8bn | at 2021-07-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥86.0bn | at 2022-07-20 | Cons. | Liabilities |
| Total liabilities | ¥75.7bn | at 2022-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥84.3bn | at 2022-07-20 | Cons. | Net assets |
| Net assets / equity | ¥83.3bn | at 2022-01-20 | Cons. | Net assets |
| Net assets / equity | ¥86.7bn | at 2021-07-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.9bn | at 2022-07-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.6bn | at 2022-01-20 | Cons. | Cash and deposits |
| Cash & equivalents | ¥28.8bn | at 2022-07-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2022-01-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2021-07-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.7bn | at 2021-01-20d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥423m | 2022-01-21 → 2022-07-20 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.1bn | 2021-01-21 → 2022-01-20 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2021-01-21 → 2021-07-20 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.8bn | 2022-01-21 → 2022-07-20 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.5bn | 2021-01-21 → 2022-01-20 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.3bn | 2021-01-21 → 2021-07-20 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.7bn | 2022-01-21 → 2022-07-20 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.7bn | 2021-01-21 → 2022-01-20 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥61m | 2021-01-21 → 2021-07-20 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-55.54 | 2022-01-21 → 2022-07-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.77 | 2022-04-21 → 2022-07-20d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥254.2 | 2021-01-21 → 2022-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.36 | 2021-01-21 → 2021-07-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.62 | 2021-04-21 → 2021-07-20d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.3% | at 2022-07-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.2% | at 2021-07-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-07-20 | −¥302m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-07-20 | −¥302m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-07-20 | −¥615m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-07-20 | ¥54.0bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-07-20 | ¥54.0bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-07-20 | ¥21m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-07-20 | ¥1.4bn |
| jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-07-20 | −¥269m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-07-20 | ¥10.8bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-07-20 | ¥10.8bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-07-20 | ¥4m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-07-20 | ¥908m |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-07-20 | ¥9.3bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-07-20 | ¥9.3bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-07-20 | −¥735m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-07-20 | ¥6.0bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-07-20 | ¥5.7bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-07-20 | ¥276m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-07-20 | ¥66m |
| —segment total | revenue | 2022-01-21 → 2022-07-20 | ¥80.1bn |
| —segment total | revenue external | 2022-01-21 → 2022-07-20 | ¥79.8bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-07-20 | ¥302m |
| —segment total | segment profit | 2022-01-21 → 2022-07-20 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2021-01-21 → 2021-07-20 | −¥324m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-21 → 2021-07-20 | −¥324m |
| Reconciling Itemsreconciling | segment profit | 2021-01-21 → 2021-07-20 | −¥721m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2021-01-21 → 2021-07-20 | ¥57.8bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2021-01-21 → 2021-07-20 | ¥57.7bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-07-20 | ¥30m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2021-01-21 → 2021-07-20 | ¥3.4bn |
| jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segment | segment profit | 2021-01-21 → 2021-07-20 | −¥399m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue | 2021-01-21 → 2021-07-20 | ¥11.1bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue external | 2021-01-21 → 2021-07-20 | ¥11.1bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-07-20 | ¥7m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | segment profit | 2021-01-21 → 2021-07-20 | ¥804m |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue | 2021-01-21 → 2021-07-20 | ¥5.7bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue external | 2021-01-21 → 2021-07-20 | ¥5.7bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | segment profit | 2021-01-21 → 2021-07-20 | −¥352m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2021-01-21 → 2021-07-20 | ¥5.7bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2021-01-21 → 2021-07-20 | ¥5.4bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-07-20 | ¥286m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2021-01-21 → 2021-07-20 | ¥49m |
| —segment total | revenue | 2021-01-21 → 2021-07-20 | ¥80.2bn |
| —segment total | revenue external | 2021-01-21 → 2021-07-20 | ¥79.9bn |
| —segment total | revenue intersegment | 2021-01-21 → 2021-07-20 | ¥324m |
| —segment total | segment profit | 2021-01-21 → 2021-07-20 | ¥3.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 551
| Item | Context | Value | Unit |
|---|---|---|---|
| Income from payments from non controlling interests associated with the establishment of a consolidated subsidiary fin cf | CurrentYTDDuration | － | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | Prior1YTDDuration | -1163000000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | CurrentYTDDuration | － | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Proceeds from sales of treasury stock fin cf | Prior1YTDDuration | 53000000 | JPY |
| Proceeds from sales of treasury stock fin cf | CurrentYTDDuration | 65000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -61000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 1732000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -53000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 161000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -2617000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -1304000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 32687000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 30072000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 30069000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 28767000000 | JPY |
| Promotion expenses sga | Prior1YTDDuration | 13071000000 | JPY |
| Promotion expenses sga | CurrentYTDDuration | 8645000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 1137000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 1120000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 251000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 231000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 57733000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 5711000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 5395000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00424-000FoodBusinessReportableSegmentsMember | 11081000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 79922000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 79922000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 30000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 286000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00424-000FoodBusinessReportableSegmentsMember | 7000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 324000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -324000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 57764000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 5711000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 5682000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00424-000FoodBusinessReportableSegmentsMember | 11088000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 80247000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -324000000 | JPY |
| Net sales | Prior1YTDDuration | 79922000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 3363000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -352000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 49000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |